Print

Print


Thursday, September 27, 2001
'Brain pacemaker' for Parkinson's backed
Implanting small electrodes had more benefits than surgery
in advanced cases, a study found.
By Thomas H. Maugh 2d
LOS ANGELES TIMES

Implanting minute electrodes in the brain is the most effective
treatment for advanced Parkinson's disease and has fewer side
effects than widely used surgeries that destroy brain tissue,
an international team will report today.

The technology, a kind of brain pacemaker, "can literally restore
patients to independent function" when conventional drugs
can no longer help them, said Dr. C. Warren Olanow of the
Mount Sinai School of Medicine in New York City,
who co-chaired the study being reported in today's New England
Journal of Medicine.

The implants could be used effectively in as many as 200,000 of the
nation's one million Parkinson's patients, he added.

Although surgical destruction of small areas of the brain may still
have a role in a small number of Parkinson's patients, he said, that
operation "basically should no longer be done."

Parkinson's, which strikes as many as 100,000 Americans each year,
is characterized by severe tremors and rigidity in the limbs and loss
of muscle control. Its cause is unknown.

Researchers have found that abnormal brain signals in Parkinson's
are produced by two small regions of the brain, the globus pallidus
and the subthalamic nucleus. In the implant procedure, tiny
electrodes are implanted in brain tissue and the tissue is bathed in
high-frequency radiation.

The stimulation has the same benefit as destruction of the tissue,
but without the side effects. A small device similar to a pacemaker
is implanted under the skin to power the electrodes. The device
itself costs about $10,000, and the entire procedure as much as
$30,000.

In research financed by Medtronic Corp. of Minneapolis, which
manufactures the implant device, the team studied 134 patients
at 18 medical centers in the United States, Europe and Australia.
For 96 patients, the electrodes were embedded in the subthalamic
nucleus on both sides of the brain; for 38, the globus pallidus.

When researchers examined the results, the impact was "fantastic,"
Olanow said.

SOURCE: The Philadelphia Inquirer
http://inq.philly.com/content/inquirer/2001/09/27/national/BRAIN27.htm

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn